Role of anti-Müllerian hormone in predicting premature ovarian insufficiency after pelvic radiotherapy.

Gynecol Oncol Rep · 2026 · PMC13320243 · PMID 42388723

Europe PMC DOI

hedged sentence

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

showed a trendp = 0.069so close (0.05 < p ≤ 0.1)

Among dosimetric parameters, higher Dmin was significantly associated with POI (OR 1.046, 95% CI 1.008–1.086, p = 0.019), and higher Dmean also showed a trend toward increased risk (OR 1.016, 95% CI 0.999–1.032, p = 0.069).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.